Clinical trial
A Prospective, Randomized, Case Controlled, Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization in Children With Peanut Allergies.
NCT01625715 is registered in ClinicalTrials.gov with Gordon Sussman Clinical Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Case Controlled, Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization in Children With Peanut Allergies.
- Lead sponsor
- Gordon Sussman Clinical Research
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 31, 2011
- Completion date
- September 30, 2012
- Enrollment
- 6 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
peanut allergies in children